Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-17-021098
Filing Date
2017-12-22
Accepted
2017-12-22 11:25:18
Documents
1
Period of Report
2017-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3486
  Complete submission text file 0001437749-17-021098.txt   5150
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Issuer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O SEROLOGICALS CORP 5565 SPALDING DR NORCROSS GA 30092
Business Address
DODD DAVID A (Reporting) CIK: 0001193607 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52091 | Film No.: 171271698